Lars Søndergaard

Showing 1-20 of 44 articles

A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention

Sathananthan J, Fraser R, Hatoum H, Barlow A, Stanová V, Allen K, Chhatriwalla A, Rieu R, Pibarot P, Dasi L, Søndergaard L, Wood D, Webb J

March 20, 2020 | 10.4244/EIJ-D-19-00939

Strengths and weaknesses of different types of TAVI study

De Backer O, Søndergaard L

February 7, 2020 | 10.4244/EIJV15I15A236

Interventions for valvular disease

Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry

Costa G, De Backer O, Pilgrim T, Kasel A, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L

February 7, 2020 | 10.4244/EIJ-D-19-00797

Interventions for valvular disease

Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions

Sathananthan J, Fraser R, Kütting M, Hensey M, Landes U, Alkhodair A, Sedaghat A, Blanke P, Toggweiler S, Leipsic J, Søndergaard L, Wood D, Webb J

February 7, 2020 | 10.4244/EIJ-D-19-00782

Interventions for valvular disease

Long-term follow-up of patients with Contained Annulus Ruptures after TAVI: the EuropeaN COntained RupturE ENCORE-registry

Breitbart P, Minners J, Pache G, Hansson N, Nørgaard BL, De Backer O, Søndergaard L, Alsanjari O, Hildick-Smith D, Abdel-Wahab M, Löbig S, Neumann F, Ruile P

February 4, 2020 | 10.4244/EIJ-D-19-00740

Interventions for valvular disease

Transcatheter aortic valve implantation with the ACURATE Neo valve: indications, procedural aspects and clinical outcomes

Kim W, Hengstenberg C, Hilker M, Schäfer U, Rudolph T, Toggweiler S, Rück A, Søndergaard L, Conradi L, Hamm C, Walther T, Möllmann H, Doss M, Holzamer A, Husser O, Belon C, Delaloye S

January 7, 2020 | 10.4244/EIJ-D-19-00908

The role of the Heart Team in the planning of aortic valve replacement

Costa G, Fukutomi M, Søndergaard L

December 20, 2019 | 10.4244/EIJV15I12A191

Will the Evolut Low Risk trial change my practice?

O'Sullivan C, Reardon M, Søndergaard L, Treede H, Jüni P, Windecker S

December 20, 2019 | 10.4244/EIJ-D-19-00587

Interventions for valvular disease

Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial

Geisler B, Jørgensen T, Thyregod H, Pietzsch J, Søndergaard L

December 6, 2019 | 10.4244/EIJ-D-18-00847

Durability of transcatheter bioprosthetic aortic valves: the story so far

Capodanno D, Søndergaard L, Tamburino C

November 15, 2019 | 10.4244/EIJV15I10A160

Interventions for valvular disease

A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane.

Iannopollo G, Romano V, Buzzatti N, De Backer O, Søndergaard L, Merkely B, Prendergast B, Giannini F, Colombo A, Latib A, Granada J, Chieffo A, Montorfano M

October 29, 2019 | 10.4244/EIJ-D-19-00951

The EuroIntervention health check 2019

Mylotte D, Byrne R, Capodanno D, Søndergaard L, Vahanian A, Serruys P

October 4, 2019 | 10.4244/EIJV15I9A135

Antithrombotic therapy after TAVI: where are we going?

Wilkins B, Fukutomi M, Søndergaard L

September 20, 2019 | 10.4244/EIJV15I7A102

Are we too simple in planning complex structural interventions? The potential role of cardiac computed tomography to prepare for percutaneous left atrial appendage closure

De Backer O, Rosseel L, Søndergaard L

June 12, 2019 | 10.4244/EIJV15I3A38

EuroIntervention and EuroPCR 2019 – together embodying the spirit of interventional cardiology

Serruys P, Mylotte D, Capodanno D, Søndergaard L, Byrne R

May 20, 2019 | 10.4244/EIJV15I1A1

Percutaneous management of an embolised MANTA large bore arteriotomy closure device

Wong Y-H, De Backer O, Søndergaard L, Bieliauskas G

May 20, 2019 | 10.4244/EIJ-D-18-01171

Coronary interventions

Intravascular assessment of coronary arteries in patients with cyanotic congenital heart disease

Tarp JB, Radu M, De Backer O, Jensen A, Celermajer D, Sorensen K, Holstein-Rathlou N-H, Engstrøm T, Søndergaard L

April 16, 2019 | 10.4244/EIJ-D-18-00882

Indications, current adoption and future perspectives for percutaneous left atrial appendage closure

Fukutomi M, De Backer O, Søndergaard L

April 16, 2019 | 10.4244/EIJV14I17A293

Interventions for valvular disease

The evolution of device technology in transcatheter aortic valve implantation

Bourantas C, Modolo R, Baumbach A, Søndergaard L, Prendergast B, Ozkor M, Kennon S, Mathur A, Mullen M, Serruys P

April 5, 2019 | 10.4244/EIJ-D-18-01048

Time to expand indications for thoracic endovascular aortic repair (TEVAR) in the setting of aortic dissection?

Bieliauskas G, Søndergaard L, De Backer O

April 5, 2019 | 10.4244/EIJV14I18A317

Latest news

NEW ISSUE

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

March 20, 2020

JAA

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

March 24, 2020

Editorial

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

March 20, 2020

Trials Book

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

Defining procedural MI - does it matter (spoiler alert - it does!)

Gregg W Stone

March 24, 2020

JAA

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

March 24, 2020

Lars Søndergaard

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke